ArticleThe Prostate2013

Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors.

Yue Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.